• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Fueling Cognitive Health through Nutrition & Supplementation

    2020 State of the Industry: High Expectations

    2020 International Buyers' Guide

    Clean Label Questions: Anything But ‘Short and Sweet’

    Key Trends in Functional Foods & Beverages for 2020
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice

    Kaneka Extends Deadline for Innovation Contest

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Kaneka Extends Deadline for Innovation Contest

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report

    Obesity and Gum Disease May Have Common Connection: Inflammation
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    Obesity and Gum Disease May Have Common Connection: Inflammation

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BatchMaster Software, Inc.

    Sabinsa Corporation

    MitoCarn (Alfasigma)

    Shanghai Freemen

    ExcelVite Sdn. Bhd.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    MitoCarn (Alfasigma)

    Shanghai Freemen

    PLT Health Solutions

    BatchMaster Software, Inc.

    Bioenergy Life Science, Inc. (BLS)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Healthcare Under Trump: What Can the Practitioner Channel Expect?

    It remains to be seen how the new administration will treat the nutrition industry, but here’s what we know.

    Healthcare Under Trump: What Can the Practitioner Channel Expect?
    Related CONTENT
    • In the Post-Election Lull, Cultivate Clinical Allies
    • State of the Industry Update & Outlook for 2017
    • The Post-Truth Reality
    • Starbucks Unveils New Leadership Structure
    • UNPA Names New VP, Regulatory & Compliance
    Erik Goldman, Holistic Primary Care03.01.17
    How will holistic medicine and the practitioner-focused nutraceutical sector fare under the Trump administration? It’s a big question with no obvious answer. Our fate will be shaped largely by what the new administration does with healthcare at large. And that is still full of unknowns.

    Some industry thought leaders envision a brighter future under a market-friendly, pro-business, anti-regulation administration. Others see danger and instability.

    With loud promises to obliterate Obamacare, a Republican majority in Congress, and an electoral base likely to demand action, the 45th president certainly has the legislative clout to drive big changes in how healthcare is financed, and possibly how it is practiced. 

    But Trump and company are already discovering that “repeal and replace” is easier said than done. First, many parts of the Affordable Care Act—like protections for preexisting conditions—are popular with Republican voters. Millions of poor and working-class Trump supporters could find themselves uninsured if the administration goes with the more extreme repeal proposals.

    Second, short of a complete dictatorial overthrow of checks and balances, it is actually quite difficult to unmake a U.S. law once it’s on the books. And that’s a good thing. If rewriting laws were easy, we’d be living in a different country every time there was an administration change. 

    A massive law like ACA, which affects multiple branches of government, several of the largest private industries, 17% of the GDP, and literally tens of millions of people is not something you change with a pen stroke. 

    ‘Nothing is Clear’
    Assuming the president will ultimately adhere to the fundamentals of legislative process, a Trump healthcare remake will face the same complex congressional wrangling as any law ever proposed—even with a Senate and House majority.

    Whatever changes are coming, they won’t be fast or easy.

    “There’s no way we can pretend the law (the ACA) doesn’t exist, or that it can be easily repealed and replaced. There’s wide disagreement even among Republicans about what the ‘repeals’ and ‘replaces’ should be,” said Michael Leavitt, former head of Health & Human Services under George W. Bush, and a three-time governor of Utah. 

    Speaking last December at the Population Health Colloquium—a conference of healthcare administrators—Mr. Leavitt said he expects action on healthcare in the coming years, but the direction is unclear.

    He added that while Nov. 8 was a victory day for Republicans, the GOP has only a two-vote margin in the Senate that could be easily lost come 2018. “Much of what will be proposed for repeal and replace will need 60 votes. Republicans don’t have that margin in the Senate.”

    According to a recent survey of 426 primary care physicians published in the New England Journal of Medicine, only 15% say they support full repeal of Obamacare. None of the self-identified Democrats, and only 32% of the Republicans support repeal. Even among physicians who voted for Trump, only 38% want the administration to scuttle the ACA.

    Almost all (95%) support protections for people with pre-existing conditions.

    Is the Price Right?
    Dr. Tom Price, who was recently confirmed as Secretary of Health & Human Services, is an avowed opponent of the ACA, and no fan of government-funded healthcare in general, though he has benefitted from it in many ways.

    An Atlanta orthopedic surgeon with a net worth upward of $13 million, and investment ties to biomedical device companies, Dr. Price is a political and cultural conservative who has taken strong positions against abortion, gun control, environmental regulations, Planned Parenthood, National Public Radio, emergency mortgage relief, and increased tobacco regulation.

    He is also an outspoken voice for physician independence, direct-pay practice, health savings accounts, malpractice reform, and health insurance tax credits.

    In 2015, while in Congress, Dr. Price floated an ACA repeal called the “Empowering Patients First Act.” Among other things, it proposed: nullification of all Obamacare mandates; tax credits of up to $3,000 on private insurance; allowing insurers to set surcharges based on health status (thus cutting protection for pre-existing conditions); expanding HSAs; blocking Medicaid expansion; and cutting constraints on private contracting between physicians and Medicare patients.

    Dr. Price is controversial among physicians; some believe that having a doctor at the top federal healthcare post will make a positive difference for clinicians and their patients. Others see his extreme conservatism as a threat to the nation’s well-being—especially the nation’s poor.

    New Meaning to ‘R n’ R’
    The White House has yet to give any details about its repeal-and-replace plan, but in January, House Speaker Paul Ryan updated his policy paper called “A Better Way: Our Vision for a Confident America,” which could become a blueprint for Trump’s healthcare remix. It incorporates many features from Dr. Price’s bill, though it retains protections for pre-existing conditions.

    The issue of pre-existing conditions could be the Achilles’ heel for Trump’s repeal effort. Any plan that blocks insurers from cherry-picking based on health status while simultaneously nixing the ACA mandates that force healthier people to buy into the system will threaten insurance industry solvency. A plan like Mr. Ryan’s, which keeps the parts of Obamacare that Republican voters like while scrapping the rest, would pit the demands of the insurance lobby against the needs of President Trump’s much-vaunted “base,” and risks alienating both. 

    HSA! HSA!!
    Republican emphasis on HSAs appeals to many in the holistic field. Tom Blue, the Institute for Functional Medicine’s director of strategic development, is hopeful about expanded HSAs. These accounts are already vital for the fiscal survival of many functional medicine practices. Expanded HSAs will, he believes, lead to expanded public access to functional medicine.

    He acknowledged, however, that HSAs will do little for poor people or low-wage workers who earn too much to qualify for Medicaid but not enough to afford private insurance.

    Mr. Blue sees both President Trump and Dr. Price as supportive of the kind of direct-pay models many functional practitioners favor. He also believes community-based cost-sharing plans like Liberty HealthShare, will see a boost under the new president. This, he said, is a sunny prospect for functional medicine.

    Overall, though, he predicted that President Trump’s healthcare changes will be more subtle than substantive. “If you accept the basic premise that we want the majority of Americans to have some basic level of coverage, then you have to have certain things in place to make it financially viable. You’re not going to win elections if you screw everyone with a pre-existing condition.”

    For naturopaths, ACA repeal presents a conundrum. Mike Jawer, director of government and public affairs for the American Association of Naturopathic Physicians (AANP), also sees HSA expansion as a good thing for the field.

    But a complete repeal of the ACA would kill Section 2706—the much-praised “Non-Discrimination in Healthcare” provision that obliges insurers to reimburse all licensed practitioners of a given service if that service is within a practitioner’s legally-recognized scope. Under the law, insurers are supposed to reimburse licensed naturopaths for primary care services.

    Though implementation has been inconsistent, Section 2706 has expanded ND reimbursement in some states. Most naturopaths, Mr. Jawer said, would hate to see it killed off.

    Naturopathy has a public image of being “left of center,” but Mr. Jawer said the profession is actually quite politically diverse. “In Arizona we’ve had licensure since 1935, and in Montana since 1991. These are places known for being conservative. That counterbalances the left-leaning persona of NDs in Oregon and Washington.”

    AANP has plans to tap into the iconoclastic spirit that got President Trump elected. “Our profession is very much in sync with what seems to be a lesson from the campaign: people want non-conventional solutions,” said Mr. Jawer. “That’s exactly what naturopathic physicians are trained in—alternatives to Big Pharma and Big Medicine.”

    De-Regulate at Our Own Risk
    It’s no secret that President Trump, like many in his circle, holds federal regulators in extreme contempt. He has demeaned the Food and Drug Administration as “the food police,” and on his watch the FDA could very well be neutered.

    The White House has been short on specifics, but the top pick to head FDA is Jim O’Neill, a libertarian who runs Trump donor (and PayPal founder) Peter Theil’s Mithril Capital Management.

    Lauded by many in the investment and biotech sectors, Mr. O’Niell detests FDA’s status quo, claiming that burdensome regulations and costs strangle innovation and kill people.

    He’s a strong supporter of the “right to try,” which would take FDA out of determining drug and device efficacy, and limit the agency strictly to ensuring minimum safety. The free market is the best arbiter of efficacy, according to Mr. O’Neill.

    Given our industry’s long, contentious relationship with the FDA, there’s no doubt many supplement company executives won’t be shedding tears if the new administration decides to castrate the regulators.

    But before we pop champagne corks and celebrate a new era of laissez-faire, it is important to consider the long-term consequences. Diminution of FDA power might sound like a great idea, but deregulation could have serious blowback.

    In the void of a weakened FDA, state attorneys general as well as plaintiffs lawyers could decide to pick up the slack, miring the industry in countless lawsuits—a slow and miserable death by 1,000 cuts. Even if the FDA and FTC are curtailed, and there’s an industry-friendly guy in the White House, supplement critics like Dr. Pieter Cohen and Paul Offit are not going away. Weakening the FDA will only give more credence to their argument that the industry is “unregulated”.

    And if you’re concerned about the flood of contaminated raw materials, spiked ingredients, and generally crappy products tainting the market, imagine what the scene will be like after a few years of Trumpian deregulation.

    Of course, few people will notice toxins in their supplements if Scott Pruitt, President Trump’s pick to head the Environmental Protection Agency, has his way and scuttles decades of environmental regulations. We’ll have lots more airborne, water-borne, and food-borne toxins to worry about.

    Vaccine Fever
    The president’s assertions that vaccines can cause autism and his promise to create a vaccine review committee—headed by liberal icon and vaccine critic Robert Kennedy—drew applause from many advocates of natural medicine. They see it as an indicator that the new president will challenge medical orthodoxy across the board. 

    Others see the vaccine claim as anti-science, likening it to his climate change denial, his willingness to censor federally funded scientists, and his talent for making up stats about nearly everything—from the size of his inauguration audience to the incidence of terrorism.

    It remains to be seen whether the administration will follow through on the promised vaccine commission, and whether the president’s anti-establishment stance on vaccines signals true open-mindedness or ignorance.

    Trump’s Supplement Blunder
    Donald J. Trump is not a stranger to our industry. In 2009, he licensed his name and logo to Ideal Health, a multi-level vitamin marketing company. With Mr. Trump himself fronting the launch, the enterprise—called The Trump Network—usurped concepts from functional and personalized medicine to sell “customized” wellness protocols guided by an unverified, proprietary urine test. At peak, more than 20,000 independent sellers paid fees to join the network and sell the kits.

    The company was initially successful with annual growth rates of 300%. But the company’s management blundered, stopped paying commission checks, and the network began to tank. Mr. Trump’s licensing agreement ended in 2011 and was not renewed.

    Mr. Trump is not the only GOP heavyweight to flirt with supplements. Dr. Ben Carson, the nominee to head Housing & Urban Development, has been a paid speaker for Mannatech, one of the largest multi-level supplement companies.

    Former Arkansas governor Mike Huckabee starred in infomercials promoting a “Diabetes Solution Kit” that promised to prevent people from becoming “a loyal pill-popping, finger-pricking, insulin-shooting customer so Big Pharma and the mainstream medical community can rake in over $100 billion.”

    It remains to be seen how the Trump administration will tackle the challenges of healthcare, and how it will treat the nutrition industry.

    If there’s anything that’s become clear about the nation’s new leader, it’s that he prefers to operate within a loud cloud of misinformation, does not respond well to criticism, and likes to keep people guessing about what he will and will not do.

    For an in-depth look at how the changes in Washington may affect our industry, join us for the 5th annual Practitioner Channel Forum, April 26-28, at the Marriott Coronado Island in San Diego. Featured speakers include: Dr. Joe Pizzorno, Duffy MacKay, Todd Harrison, Steve Holmes, Michael Levin, Dr. Bridget Briggs, and many more—and get fresh practitioner data from Holistic Primary Care, Nutrition Business Journal, and the SORD study. For more information visit: www.TPCForum.com


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other heathcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, an annual executive level gathering focused on challenges and opportunities in the health practitioner channel. For more information: www.TPCForum.com.
    Related Searches
    • Vitamin
    • ftc
    • fda
    • survey
    Related Knowledge Center
    • Regulations
    • Medical Nutrition
    • Healthcare Trends
    Suggested For You
    AND Asks Congress to Fund Food, Nutrition & Health Programs AND Asks Congress to Fund Food, Nutrition & Health Programs
    FDA Nominee Uses Supplements Daily and Promises Access During Tenure FDA Nominee Uses Supplements Daily and Promises Access During Tenure
    Are We at The End of the ‘Integrative Medicine’ Era? Are We at The End of the ‘Integrative Medicine’ Era?
    Weighty Matters: Implications for Repeal of the Affordable Care Act Weighty Matters: Implications for Repeal of the Affordable Care Act
    AHPA: FDA Acknowledged About 25% of Recent NDI Notifications With No Objection AHPA: FDA Acknowledged About 25% of Recent NDI Notifications With No Objection
    Trump Taps Scott Gottlieb to Lead FDA Trump Taps Scott Gottlieb to Lead FDA
    Wellness Means Business Wellness Means Business
    Oral Solid Dosage Outsourcing: Trends & Challenges Oral Solid Dosage Outsourcing: Trends & Challenges
    Global Wellness Economy Estimated at $3 Trillion Global Wellness Economy Estimated at $3 Trillion
    UNPA Names New VP, Regulatory & Compliance UNPA Names New VP, Regulatory & Compliance
    Starbucks Unveils New Leadership Structure Starbucks Unveils New Leadership Structure
    In the Post-Election Lull, Cultivate Clinical Allies In the Post-Election Lull, Cultivate Clinical Allies
    State of the Industry Update & Outlook for 2017 State of the Industry Update & Outlook for 2017
    The Post-Truth Reality The Post-Truth Reality

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Quality & Safety | Regulations | Testing
      Developing Scientific Support for Product Claims

      Developing Scientific Support for Product Claims

      Generally accepted scientific principles should be used to determine the quality of studies used as evidence to substantiate a claim.
      By Greg Stephens, Windrose Partners & Sanford W. Bigelow, PhD, DABT, Vanguard Global Associates LLC 11.05.19

    • Dietary Supplements | Herbs & Botanicals | Natural/Organic | Quality & Safety | Regulations | Testing
      The Wild West Sells More than Just CBD

      The Wild West Sells More than Just CBD

      Self-determined GRAS is not a cure-all for NDINs, so be responsible and conduct the necessary safety and toxicology work.
      By Todd Harrison, Venable 11.05.19

    • Regulations | World Markets
      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Regulatory Harmonization in Europe: Setting Daily Reference Values

      Maximum intake amounts of many micronutrients are still not regulated throughout the EU.
      By Joerg Gruenwald, analyze & realize ag 11.05.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Research | Testing
      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      Botanical Science: Post-Exercise Benefits & Neuroprotective Potential

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 11.05.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Medical Nutrition | Quality & Safety | Regulations
      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      CBD in the Clinic: How Practitioners View Life After the Farm Bill

      Holistic, functional medicine practitioners see therapeutic value of CBD and have confidence in its efficacy for a range of common health concerns.
      By Erik Goldman, Holistic Primary Care 10.07.19

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      CBD Insurance: ‘The Perfume of the Premium’ Strengthens

      The insurance marketplace for hemp growers and CBD manufacturers will continue to expand.
      By Sheldon Baker, Baker Dillon Group LLC 10.07.19


    • Antioxidants | Dietary Supplements | Digestive Health | Herbs & Botanicals | Minerals | Research | Vitamins
      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      Cinnamon: A Journey from Traditional Flavor to Modern Health Applications

      A remedy for many ailments in Ayurvedic medicine, science continues to uncover new uses for this common flavoring agent.
      By Dilip Ghosh, PhD, FACN, nutriConnect 10.07.19

    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      Clinical Nutrition: A New Market Opportunity

      Clinical Nutrition: A New Market Opportunity

      Clearer language and scientific documentation for product benefits could open new doors for nutraceuticals in healthcare settings.
      By Greg Stephens, Windrose Partners, & Sheila Campbell, PhD, RD 09.09.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      CBD Regulatory Status Update: The Chaos Continues

      CBD Regulatory Status Update: The Chaos Continues

      FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.
      By Todd Harrison, Venable 09.09.19


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Regulations | World Markets
      Regulatory Harmonization in Europe: CBD Case Study

      Regulatory Harmonization in Europe: CBD Case Study

      Despite long-standing efforts, many EU regulatory standards are still out of alignment.
      By Joerg Gruenwald, analyze & realize ag 09.09.19

    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Mile High Labs: Stephen Mueller & The Mile High Monster

      Mile High Labs: Stephen Mueller & The Mile High Monster

      As chief technology officer and founder, he is the technical visionary of Mile High Labs and is designing/building and operating the future of hemp extraction.
      By Sheldon Baker, Baker Dillon Group LLC 07.03.19

    • Dietary Supplements | Regulations | World Markets
      Australia: Leading Regulation of Complementary Medicines

      Australia: Leading Regulation of Complementary Medicines

      The TGA recently implemented a Compliance Rating Scheme for listed medicines.
      By Dilip Ghosh, PhD, FACN, nutriConnect 07.03.19

    • Dietary Supplements | Regulations
      DSHEA Discussion: Assessing Standards for Scientific Evidence

      DSHEA Discussion: Assessing Standards for Scientific Evidence

      Adjusting the health claims system could encourage more clinical trials and benefit consumers.
      By Todd Harrison, Venable 06.03.19

    • Dietary Supplements | Regulations | World Markets
      Non-Specific Health Claims: Beyond the Letter of the Law

      Non-Specific Health Claims: Beyond the Letter of the Law

      These statements are acceptable as long as they are either accepted generic descriptors or accompanied by a specific health claim.
      By Joerg Gruenwald, analyze & realize ag 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19

    Breaking News
    • International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    • Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    • Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    • Kaneka Extends Deadline for Innovation Contest
    • Maternal 5-MTHF Levels Predict Fetal Folate Status
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • 2020 International Buyers' Guide
    • 2020 State of the Industry: High Expectations
    • Fueling Cognitive Health through Nutrition & Supplementation
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    BASF Doubling Automotive Refinish Coatings Production Capacity at Jiangmen, China Site
    AkzoNobel’s Wanda Vehicle Refinishes Brand Celebrates 85th Anniversary
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Biomerics Forms New Business Unit
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Stevanato Group Begins Construction on TEC
    Bayer, CHOP Partner to Develop Oral NRT
    Novasep Launches oXYgene for Boosting Viral Vector Production
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pantone Names Classic Blue the 2020 Color of the Year
    Burst Launches Black Expanding Dental Floss
    Glossier Enters Nordstrom for the Holidays
    Happi

    Latest Breaking News From Happi

    Raining Rose Expands Exec Team
    Sozio Builds a New Facility
    Laverne Cox Is Matrix Ambassador
    Ink World

    Latest Breaking News From Ink World

    Geoff Loftus Joins EFI
    Berlin Packaging Wins 2 WorldStar Awards
    Graphic Village Expands Offerings with Canon Solutions America
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Converters Expo schedules return to Green Bay, WI
    Schreiner MediPharm and PragmatIC form strategic partnership
    Herma's labelstocks receive new certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS
    CES 2020: 'Where Tech Changes Business'
    Global Flexible Display Market Size to Increase at a CAGR of 28.1% Through 2025: GVR

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.